Xin Zhou

Xin Zhou

Assistant Professor
Xin Zhou
Antibodies, checkpoint inhibitors, and CAR-T cells have all been successful in leveraging the immune system against disease, but these treatment strategies still have limitations. Our laboratory utilizes protein engineering and synthetic biology approaches to probe and direct anti-tumor immune responses. We design and engineer dynamic, functional signaling proteins that respond to specific protein post-translational modifications, conformations, or complexes. We hypothesize that these conditionally activated proteins will be able to recognize cancer-specific antigens, report tumor microenvironment characteristics, or help build synthetic cell signaling pathways, and therefore can be harnessed to enact specific anti-tumor responses. 

Our research focuses on two high-level questions: (1) How are molecules and signaling networks spatiotemporally regulated within the tumor microenvironment and  (2) What designs of biosensors and biomedicines can provide more precise reporting and perturbation of disease-specific signaling. The lab currently works on three interrelated research topics: (1) Building artificial kinases and signaling cascades by evolving phosphotyrosine recognition, (2) Engineering single-domain antibody (sdAb)-based biosensors to interrogate disease signaling dynamics, and (3) Building multi-specific biomolecules that modulate membrane proteins in a different way than all current immunotherapy strategies. Our ultimate goal is to leverage molecular engineering to gain a deeper fundamental understanding of malignancies and to discover new avenues for therapeutic intervention.

Contact Information

Dana Farber Cancer Institute
450 Brookline Avenue, LC-3116
Boston, MA 02215

Community or Program Affiliation



Year entered